Sharon Lim

1.1k citations
16 papers · 618 indexed · h-index 12
Topics
Alzheimer's disease research and treatments (6 papers)PI3K/AKT/mTOR signaling in cancer (5 papers)Neuroinflammation and Neurodegeneration Mechanisms (5 papers)

In The Last Decade

Sharon Lim

16 papers receiving 612 citations

Peers

Sharon Lim
Comparison fields: 5 of 87
  • Molecular Biology 316
  • Physiology 193
  • Cellular and Molecular Neuroscience 112
  • Neurology 110
  • Oncology 49
Replace Aleksandra Szybińska with:
Aleksandra Szybińska Poland
Eva del Valle Spain
Serena Stanga Italy
Masaaki Takemura Japan
Elizabeth Gowing Canada
Uta Rickert Germany
Tatsuro Nishi United States
Rachit Bakshi United States
Simon Cheung Canada
Honglian Li China
Sharon Lim relative to Aleksandra Szybińska Poland Aleksandra Szybińska's profile →
Citations per field
00.5×1.7×
Aleksandra Szybińska · 1×
Citations per year

Countries citing papers authored by Sharon Lim

Since Specialization
Citations

This map shows the geographic impact of Sharon Lim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sharon Lim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sharon Lim more than expected).

Fields of papers citing papers by Sharon Lim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sharon Lim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sharon Lim. The network helps show where Sharon Lim may publish in the future.

Co-authorship network of co-authors of Sharon Lim

This figure shows the co-authorship network connecting the top 25 collaborators of Sharon Lim. A scholar is included among the top collaborators of Sharon Lim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sharon Lim. Sharon Lim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
#WorkIndexed citations
1 7
2 8
3 27
4 31
5 12
6 94
7 131
8 22
9 23
10 118
11 1
12 26
13 34
14 35
15 3
16 46

About Sharon Lim

Sharon Lim is a scholar working on Neurology, Biological Psychiatry and Hematology, having authored 16 papers that have together received 618 indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (6 papers), PI3K/AKT/mTOR signaling in cancer (5 papers) and Neuroinflammation and Neurodegeneration Mechanisms (5 papers). The work is most often cited by research in Biological Psychiatry (48 citations), Neurology (110 citations) and Physiology (193 citations). Sharon Lim has collaborated with scholars based in United States, Singapore and China. Frequent co-authors include Carlos J. Rodríguez‐Ortiz, Masashi Kitazawa, Marie‐Véronique Clement, Jason Kilian, Rodrigo Medeiros, David Cheng, S. Tiong Ong, Charles Chuah, Soo‐Yong Tan and Matthew R. Janes. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026